Evolution of the Average Target: GlaxoSmithKline Pakistan Limited

Evolution of the Target Price: GlaxoSmithKline Pakistan Limited

Changes in Analyst Recommendations: GlaxoSmithKline Pakistan Limited

ff0b3b130f2.CjZ6ifJFDXPelEk567tcNhsuapqMZzJE2j8xobLQX2M.bm4vuMAmPkW7-Xt6ju4zYEtqHdPCOHMi7XFf29ucHTJHeg3NrRN5OK_ALg~07dbff49ca238cfa45a3857dfc79d899

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
- +62.23%
+11.99%
+2.47%
+5.4%
+4.17%
+5.45%
+27.21%
-6.12%
+5.12%
+21.56%
Average +13.95%
Weighted average by Cap. +8.25%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
314.37PKR
Average target price
510.00PKR
Spread / Average Target
+62.23%
High Price Target
510.00PKR
Spread / Highest target
+62.23%
Low Price Target
510.00PKR
Spread / Lowest Target
+62.23%

Analyst Consensus Detail

Consensus revision (last 18 months)

  1. Stock Market
  2. Stocks
  3. GLAXO Stock
  4. Consensus GlaxoSmithKline Pakistan Limited